Synthetic Peptide
DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.
STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-175992 |
| Réf. fabricant | 15246279 |
| Gene ID (Entrez) | 9263 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q9UEE5 |
| Nom usuel | Human DRAK1 |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | STK17A |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
